Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/2289
Title: Inhibition of human platelet aggregation by Choisyaternatine isolated from Choisya ternata (Rutaceae)
Authors: Ikarastika Rahayu Abdul Wahab 
Nikki S. H. Wong 
Maria J. Santoz-Martinez 
Fabio Boylan 
Keywords: Choisya ternata;platelet aggregation;choisyaternatine;skimmianine
Issue Date: Dec-2021
Publisher: UMK Publisher.
Abstract: 
A newly reported alkaloid was isolated from the hexane extract of Choisya ternata Kunth. (Rutaceae) leaves, identified as 6,8-Dimethoxy-7-(3-methylbut-2- enyloxy)quinolin-2-ol (choisyaternatine) (A), together with the known compounds skimmianine (B), lup-20(29)-en-3β-ol (lupeol) (C) and tecleamaniensine A (D). Compounds C and D are reported for the first time in this species. The structures of isolated compounds were elucidated by extensive spectroscopic analyses and comparison with previously reported spectroscopic data. The structure of choisyaternatine was further confirmed based on X-ray data analysis. Anti-platelet activity of hexane extract, choisyaternatine and skimmianine was also evaluated. The extract was able to significantly inhibit collagen-induced platelet aggregation at all concentrations tested (25, 50 and 100 μg/ml). The new compound, choisyaternatine, has shown a significant inhibition of collagen-induced platelet aggregation demonstrated in a concentration dependent manner from 250 μM. The concentrations which inhibit 50% of platelet aggregation (IC50) were found to be 564 μM for skimmianine and 698 μM for choisyaternatine. This is also the first report for the antiplatelet activity for this plant and these alkaloids using human platelets.
Description: 
Mycite
URI: http://hdl.handle.net/123456789/2289
ISSN: 2462-2389
Appears in Collections:Journal Indexed Era/Google Scholar and Others - FSDK

Files in This Item:
File Description SizeFormat
2-9(12)-80-87-Ikarastika.pdf755.28 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.